Strides wins CCI approval to buy 7 brands of J&J

As per the deal, Strides will buy Johnson and Johnson's (J&J) seven brands in dermatology, anti-emetic and pain management segments.

rubber-23415-640

Strides will buy J&J's seven brands in dermatology, anti-emetic and pain management segments

Strides Shasun has received Competition Commission of India (CCI) approval to acquire seven brands from consumer healthcare firm Johnson and Johnson (J&J).

"... approves acquisition of certain brands of Johnson and Johnson by Strides Shasun Limited," CCI tweeted.

Last year, Strides has struck a deal to acquire seven brands from J&J.

As per the deal, Strides will buy J&J's seven brands in dermatology, anti-emetic and pain management segments. The brands that the company will acquire include Otogesic ear drops, Ethnorub ointment and Stugil tablets.

Financial details of the transaction were not disclosed.

 

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

GST

GST: Boon or Bane for Healthcare?

Send this article by email

X